Michael Levitan News Today

Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. announces that at its Annual General Meeting of Shareholders held today, all proposals were approved.The shareholders approved the...

Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF BONDHOLDERS. IF BONDHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD SEEK THEIR OWN FINANCIAL AND LEGAL ADVICE...

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary...

Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. confirms it will report its preliminary first quarter 2024 financial results, for the period ended March 31, on Wednesday, May 8, 2024. ...

Recognition given for achievement in commercializing Joenja® , a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands,...

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ...

18.04.2024 - NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Pharming Group N.V. launches new convertible bond ...